文献速递糖尿病

终末期肾病合并燃尽型糖尿病患者通过连续血糖监测、糖化血红蛋白、果糖胺和糖化白蛋白评估血糖控制

Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
PubMed 文献 · Diabetes Care · 2024-01-01

本研究为初步前瞻性研究,纳入燃尽型糖尿病(n=20)与无糖尿病史(n=20)的血液透析终末期肾病患者,采用连续血糖监测(Dexcom G6)、HbA1c、果糖胺和糖化白蛋白评估血糖控制。燃尽型糖尿病组CGM日间血糖更高、70-180 mg/dL范围内时间百分比更低、>250 mg/dL时间百分比更高、>180 mg/dL高血糖持续时间更长(均P<0.01);两组HbA1c和果糖胺相似,但燃尽型糖尿病组糖化白蛋白更高。CGM显示燃尽型糖尿病存在显著未诊断的高血糖,CGM和糖化白蛋白较HbA1c和果糖胺能更好评估终末期肾病患者血糖控制。

要点

  • 燃尽型糖尿病组CGM日间血糖更高、目标范围内时间更少、高血糖时间更长(均P<0.01)。
  • 两组HbA1c和果糖胺相似,燃尽型糖尿病组糖化白蛋白更高。
  • CGM和糖化白蛋白较HbA1c和果糖胺能更好评估终末期肾病患者血糖控制。

核心结论

  • CGM显示燃尽型糖尿病患者存在显著的未诊断高血糖。
  • 在终末期肾病患者中,CGM和糖化白蛋白较HbA1c和果糖胺能更好地评估血糖控制。

研究设计与样本

  • 初步前瞻性研究,纳入燃尽型糖尿病(n=20)和无糖尿病史(n=20)的血液透析终末期肾病患者。
  • 燃尽型糖尿病定义为HbA1c<6.5%且未接受降糖治疗超过6个月。
  • 采用连续血糖监测(Dexcom G6 CGM)、HbA1c、糖化白蛋白和果糖胺评估血糖控制。

主要发现

  • 燃尽型糖尿病组较无糖尿病组CGM日间血糖水平更高(P<0.01)。
  • 燃尽型糖尿病组较无糖尿病组70-180 mg/dL范围内时间百分比更低(P<0.01)。
  • 燃尽型糖尿病组较无糖尿病组>250 mg/dL时间百分比更高(P<0.01)。
  • 燃尽型糖尿病组较无糖尿病组>180 mg/dL高血糖持续时间(小时/天)更长(P<0.01)。
  • 两组HbA1c和果糖胺水平相似,但燃尽型糖尿病组糖化白蛋白水平高于无糖尿病组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with diabetes and end-stage kidney disease (ESKD) may experience "burnt-out diabetes," defined as having an HbA1c value <6.5% without antidiabetic therapy for >6 months. We aim to assess glycemic control by continuous glucose monitoring (Dexcom G6 CGM) metrics and glycemic markers in ESKD patients on hemodialysis with burnt-out diabetes. RESEARCH DESIGN AND METHODS: In this pilot prospective study, glycemic control was assessed by continuous glucose monitoring (CGM), HbA1c measures, and glycated albumin and fructosamine measurements in patients with burnt-out diabetes (n = 20) and without a history of diabetes (n = 20). RESULTS: Patients with burnt-out diabetes had higher CGM-measured daily glucose levels, lower percent time in the range 70-180 mg/dL, higher percent time above range (>250 mg/dL), and longer duration of hyperglycemia >180 mg/dL (hours/day) compared with patients without diabetes (all P < 0.01). HbA1c and fructosamine levels were similar; however, patients with burnt-out diabetes had higher levels of glycated albumin than did patients without diabetes. CONCLUSIONS: The use of CGM demonstrated that patients with burnt-out diabetes have significant undiagnosed hyperglycemia. CGM and glycated albumin provide better assessment of glycemic control than do values of HbA1c and fructosamine in patients with ESKD.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kaminski CY, Galindo RJ, Navarrete JE, et al. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes. Diabetes Care. 2024. PMID: 38085705. doi:10.2337/dc23-1276

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。